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Abstract
Background: The activity of the heterodimeric transcription factor hypoxia inducible factor (HIF) is regulated by
the post-translational, oxygen-dependent hydroxylation of its a-subunit by members of the prolyl hydroxylase
domain (PHD or EGLN)-family and by factor inhibiting HIF (FIH). PHD-dependent hydroxylation targets HIFa for
rapid proteasomal degradation; FIH-catalysed asparaginyl-hydroxylation of the C-terminal transactivation domain
(CAD) of HIFa suppresses the CAD-dependent subset of the extensive transcriptional responses induced by HIF. FIH
can also hydroxylate ankyrin-repeat domain (ARD) proteins, a large group of proteins which are functionally
unrelated but share common structural features. Competition by ARD proteins for FIH is hypothesised to affect FIH
activity towards HIFa; however the extent of this competition and its effect on the HIF-dependent hypoxic
response are unknown.
Results: To analyse if and in which way the FIH/ARD protein interaction affects HIF-activity, we created a rate
equation model. Our model predicts that an oxygen-regulated sequestration of FIH by ARD proteins significantly
shapes the input/output characteristics of the HIF system. The FIH/ARD protein interaction is predicted to create an
oxygen threshold for HIFa CAD-hydroxylation and to significantly sharpen the signal/response curves, which not
only focuses HIFa CAD-hydroxylation into a defined range of oxygen tensions, but also makes the response
ultrasensitive to varying oxygen tensions. Our model further suggests that the hydroxylation status of the ARD
protein pool can encode the strength and the duration of a hypoxic episode, which may allow cells to memorise
these features for a certain time period after reoxygenation.
Conclusions: The FIH/ARD protein interaction has the potential to contribute to oxygen-range finding, can
sensitise the response to changes in oxygen levels, and can provide a memory of the strength and the duration of
a hypoxic episode. These emergent properties are predicted to significantly shape the characteristics of HIF activity
in animal cells. We argue that the FIH/ARD interaction should be taken into account in studies of the effect of
pharmacological inhibition of the HIF-hydroxylases and propose that the interaction of a signalling sensor with a
large group of proteins might be a general mechanism for the regulation of signalling pathways.
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In animals, the response to hypoxia is mediated by an a,
b-heterodimeric transcription factor, the hypoxia induci-
ble factor or HIF. In humans, there are three different
HIFa isoforms, with HIF1a and HIF2a being better
characterised than HIF3a. The HIFb subunit is identical
with the aryl hydrocarbon receptor nuclear translocator
(ARNT). Both the level and transcriptional activity of
HIF are regulated by post-translational hydroxylation of
the HIFa, but not HIFb, subunit. In the presence of suf-
ficient oxygen, HIF1a and HIF2a undergo hydroxylation
of two proline-residues in their oxygen-dependent
degradation domain (ODD), reactions catalysed by three
Fe(II)- and 2-oxoglutarate-dependent prolyl hydroxylase
domain (PHD1-3 or EGLN1-3) enzymes [1]. In healthy
mammalian cells, PHD2 is the most important regulator
of the hypoxic response as shown by cellular [2] and
animal studies [3]. HIF1a and HIF2a also undergo
asparaginyl hydroxylation [4] of the C-terminal (CAD)
of the two transactivation domains found in HIFa
(CAD-hydroxylation). This reaction is catalysed by fac-
tor inhibiting HIF (FIH), which is also an Fe(II)- and 2-
oxoglutarate-dependent oxygenase [5,6]. HIFa prolyl
hydroxylation by PHDs very substantially increases its
binding to the von Hippel Lindau protein (pVHL),
which acts as a targeting component for an E3 ubiquitin
ligase complex and thus mediates rapid degradation of
HIFa by the proteasome. When PHD catalysis is limited
by oxygen availability, i.e. in hypoxia, HIFa degradation
is slowed, its level rises, it dimerises with HIFb and
upregulates HIF-target gene transcription. In contrast to
the PHD-dependent ODD-hydroxylation, FIH-depen-
dent CAD-hydroxylation does not affect the stability of
HIFa, but more directly decreases the transcriptional
activity of HIF by blocking the recruitment of the tran-
scriptional co-regulator p300/CBP to the CAD [4,6],
thus disrupting CAD-dependent target gene expression.
In contrast, target genes that depend on the N-terminal
transactivation domain (NAD) of HIFa are not affected
by FIH activity [7]. For reviews see [8-10].
More recently, it has become clear that HIFa is not
the only FIH substrate, but that FIH also catalyses the
hydroxylation of a wide range of other proteins [11-16].
With the notable exception of HIFa itself, all FIH sub-
strates identified to date contain an ankyrin-repeat
domain (ARD), an evolutionarily ancient structural
domain found in all kingdoms of life [17]. ARDs seem
to predominantly mediate protein-protein interactions
[18], and occur in proteins as diverse as signal transdu-
cers, ion channels, cell cycle regulators, transcriptional
regulators and chromatin-associated proteins. ARD pro-
teins contain varying numbers of ankyrin repeats (ARs).
ARs are one of the most commonly occurring protein
repeats in animals [17]. The stereotypical AR consists of
33 amino acid residues and has an L-shaped fold, which
is formed by two short a-helices, arranged in an anti-
parallel fashion, and, perpendicular to the helices, a pro-
truding loop region followed by a b-hairpin. The aspara-
gine residue targeted by FIH in some ARs is located in
the loop region. ARs stack together to form an ARD,
which, in humans, can contain up to 28 ARs. Several
studies suggest that AR-hydroxylation by FIH is wide-
spread [11-16], however its biological significance is
unclear. Studies with consensus ARDs suggest that
hydroxylation may cause an increase in the thermody-
namic stability of the ARD fold [19,20], and some evi-
dence points to a potential role for ARD hydroxylation
in signalling crosstalk in the cases of Notch [13,16] and
NFB/IBa [11]. Because the inhibition of HIFa CAD-
dependent transcription remains the only well-defined
functional outcome of the catalytic activity of FIH, ARD
proteins have been speculated to fine-tune FIH activity
towards HIFa by binding and sequestering FIH [12,21].
The discovery that FIH interacts with multiple ARD
proteins raises major questions as to the role of FIH as
an oxygen sensor. To our knowledge, the proposal that
the interaction of multiple proteins with a sensor has a
regulatory role, is unprecedented. It is unclear what
effect the competitive inhibition of FIH by ARD proteins
would have on signal processing and on the input/out-
put relation of the network. Because the proposed regu-
latory effect of ARD proteins on FIH involves multiple
interactions it is difficult to study via classical
approaches. We therefore devised and analysed a rate
equation model of HIFa CAD-hydroxylation.
Our model predicts that the presence of ARD proteins
and their hydroxylation by FIH can indeed fine-tune
HIFa CAD-hydroxylation, provided that the affinity of
FIH for ARD proteins is significantly weakened by their
hydroxylation. The simulations highlight unexpected
functional consequences of the FIH/ARD protein inter-
action for the hypoxic response: By creating an oxygen
threshold, HIFa CAD-hydroxylation is predicted to be
focused into a defined range of oxygen tensions (range
finding mechanism), the signal/response curves of HIFa
CAD-hydroxylation is predicted to become significantly
sharpened (ultrasensitivity), and, upon reoxygenation,
FIH-release is predicted to occur with a time-delay, the
length of which depends on the duration and the
strength of the preceding hypoxic period (memory
effect).
Methods
A database of human ankyrin repeats (ARs)
The SMART [22], PFAM [23] and Uniprot [24] data-
bases were searched for human AR sequences. SMART
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protein entries, PFAM Version 24 contains 2337 ankyrin
repeats corresponding to 646 protein entries in Uniprot.
Sequences that are represented incompletely in the
PFAM and SMART databases were extended to the
canonical length of 33 residues. To eliminate redun-
dancy, ARs corresponding to different entries for identi-
cal proteins were removed. All individual ARs were
assembled into a database (Additional File 1), which
includes the amino acid sequences of all repeats, the
protein names and identifiers, their position of the AR
within the ARD protein and a classification according to
sequence motifs. ARs longer than 34 or shorter than 32
residues (less than 10% of repeats) were excluded from
the set of sequences used to obtain the consensus
sequence and the sequence logos.
Kinetic modelling
Nomenclature of kinetic parameters and reaction species
Catalytic rate constants (kcat) and dissociation constants
for enzyme-substrate complexes (KD)a r ed i s t i n g u i s h e d
by superscripts, the hydroxylation rate functions (ν)f o r
the three hydroxylation reactions by subscripts, with P
for PHD-dependent HIFa ODD-hydroxylation, FH for
FIH-dependent HIFa CAD-hydroxylation, FA and for
FIH-dependent ankyrin hydroxylation. K M
P and K M
F are
the Michaelis constants of PHD and FIH for oxygen,
respectively. ks and kd are the rate constants for basal
protein synthesis and degradation, with superscripts H
and A indicating HIFa and ARD proteins, respectively.
A list of all model species is given in Table 1, a list of
parameters in Table 2.
Modelling and modelling assumptions
For the HIF-hydroxylases to act as oxygen sensors in the
proposed manner, their activity in cells must be limited
by oxygen availability. Moreover, to ensure that HIFa-
levels and the amount of HIF bound to DNA reflect the
intracellular oxygen tension at all times, ODD-hydroxy-
lation must be rate-limiting rather than degradation of
ODD-hydroxylated HIFa, complex formation with HIFb
or DNA-binding of HIF. These requirements allow us to
make the following simplifying assumptions: Firstly,
HIFb and the hydroxylase co-substrates, 2-oxoglutarate
and Fe(II), are not limiting, and secondly, the degrada-
tion of ODD-hydroxylated HIFa as well as binding of
HIF to hypoxia response elements are fast compared to
the ODD-hydroxylation reaction. Although we appreci-
ate that under some conditions these assumptions may
not be valid, for instance in some tumour cells [25,26], a
body of evidence suggests that these assumptions are
reasonable for normal cells. All simulations were done
using the open source software XPP-AUT [27]. Steady
state values were calculated by running time course
simulations at different oxygen-tensions until a steady
state was reached.
The Full Model
For the hydroxylation rate functions in the Full Model,
we take into account that free HIFa concentration
decreases by binding to the enzymes ("full model
kinetics”, see also Additional File 2). Unlike classical
Michaelis-Menten kinetics, this approach is also valid if
there is no substrate excess, a situation that is frequently
encountered in protein-protein interaction networks
[28]. Because of the expected excess of ARD proteins
over FIH, we use the Michaelis-Menten approximation
for FIH-catalysed AR-hydroxylation. The Full Model is
defined by three ordinary differential equations, which
are given in dimensionless form. The CAD-hydroxylated
forms of HIFa a n dt h eA R Dp r o t e i n sa r ed e f i n e db y
mass conservation. “Hat” (^) indicates non-dimensional
quantities expressed relative to the maximal amount of
HIFa present in the absence of oxygen, and
“prime00000000000” (’) indicates non-dimensional quan-
tities expressed relative to the basal degradation rate
constant for HIFa. Oxygen is given relative to the KM of
PHD for oxygen, which is indicated by “tilde” (~). For
details, refer to Additional File 2.
dH
d
H
tot
tot P



 =− + 11 () · (1)
dH
d
H PF H



 =− + + 11 () ·· (2)



dA
d
AA tot FA
ˆ
ˆˆ () ´ =−+ 1 (3)
The hydroxylation rate functions νP, νFH and νFA (Addi-
tional File 2, Sections 2-4) are given in dimensionless
Table 1 List of model species
Variable species
Htot all HIFa
H non-CAD-hydroxylated HIFa
HOH CAD-hydroxylated HIFa
A unhydroxylated FIH target repeats
AOH hydroxylated FIH target repeats
Constant species
Atot all FIH target ankyrin repeats
Ptot all PHD
Ftot all FIH
O2 intracellular oxygen
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expressions:
1. PHD-dependent HIFa ODD-hydroxylation( ´ P )
 ´ ´
Pc a t
P
tot
D
P
Pt o t
kP
K H P
O
O
=
++ +
⎛
⎝
⎜ ⎜
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⎟ ⎟
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1
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2
(4)
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tot tot tot tot        =− − + + − +
⎛
⎝
⎜
⎞
⎠
1
2
4
2 () ⎟ ⎟ (5)
H P  indicates HIFa that is not already bound to
PHD, i.e. the fraction of HIFa free to bind PHD,
whether it is CAD-hydroxylated or not.
2. FIH-dependent HIFa CAD-hydroxylation in the
presence of competing ARs ( ´ FH )


´ ´
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(8)
H F  indicates non-CAD-hydroxylated HIFa not
already bound to FIH, i.e. the fraction of HIFa free to
bind FIH. For a definition of a and g see Table 2.
3. FIH-dependent AR-hydroxylation in the presence of
competing HIFa( ´ FA ), where H  F is given by Eq. 7:



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Skeleton Model 1 (SKM1)
SKM1 ignores the presence of ARD proteins and
approximates both HIFa hydroxylation rate functions
( ´´ , PF H ) by Michaelis-Menten kinetics. We are left
with the differential equations Eq. 1 and Eq. 2 only. The
hydroxylation rate functions, Eq. 4 and Eq. 6, simplify to
 ´ ´
Pc a t
P
tot
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P
tot
k
K H
O
O
P =
+ +
⎛
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

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1 2
2
(11)
If binding of HIF to the DNA is fast, the fractions of
hypoxia-response elements (HRE) occupied with a non-
Table 2 Dimensionless parameter values used for the Full Model
Number Parameter description Parameter Values Source
1 PHD concentration 0.2 estimate Ptot 
2 Dissociation constant of PHD/HIFa binding K D
P  1 [29]
3( kcat for ODD-hydroxylation)/(basal HIFa degradation rate constant) ′ k cat
P 500 [31]
4 FIH concentration Ftot  1 estimate
5 Dissociation constant of FIH/HIFa binding K D
FH  1 set to same as 2
6( kcat for HIFa CAD-hydroxylation)/(kcat for HIFa ODD-hydroxylation)
 =
K
K
cat
FH
cat
FA
1 estimate
7( K M of FIH for oxygen)/(KM of PHD for oxygen)
 =
K
K
M
F
M
P
0.33 [30]
8 total concentration of FIH target ARs ˆ Atot 0 - 500 varied
9 Dissociation constant of FIH/ARD protein binding (unhydroxylated ARs) K D
FA  1 set to same as 2
10 (FIH affinity for hydroxylated)/(FIH affinity for unhydroxylated ARs) g 0 - 0.1 varied
11 (basal HIFa degradation rate constant)/(AR degradation rate constant)
 =
k
k
d
H
d
A
1 - 10 varied
12 Dissociation constant of HIF/HRE binding K D
HRE  0.3 estimate
13 Oxygen concentration  O2 0 - 1 varied
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tively, are described by the steady state expressions
HRE
H
KH
HRE
H
KH
CAD
D
HRE
CADOH
OH
D
HRE
tot
tot
=
+
=
+

 

 
the sum of which is the fraction of HREs occupied by
either form. Here, K D
HRE is the dissociation constant of
the HIF/HRE interaction, assuming all forms of HIF
bind to DNA with the same affinity. These expressions
can also be interpreted as the probability of a specific
HRE to be occupied by either species.
Skeleton Model 2 (SKM2)
SKM2 ignores HIFa and describes FIH/ARD protein
interactions only, using the differential equation Eq. 12.
The fraction of FIH that is not bound to ARD proteins
is given by Eq. 13. In contrast to the Full Model and
SKM1, in SKM2, “hat” (^) indicates non-dimensional
quantities expressed relative to the total amount of FIH-
target ankyrin repeats. In SKM2, oxygen is given relative
to the KM of FIH for oxygen, which is indicated by
“dash” (-). The parameters  “sequestration capacity”)
and b ("hydroxylation efficiency”) are defined in Eq. 14
and 15. See also Additional File 2, Section 6.
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d
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O
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ˆ
ˆ 
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
=− −
+ +
1
1 1
2
2
(12)
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A
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+
1
1  ˆ (13)
 =
def A
K
tot
D
FA (14)
 =
def kF
kA
cat
FA
d
A
tot
tot
(15)
Parameter values
Experimental information restricts the biologically rele-
vant range of parameter values and allows estimates.
The KM of PHDs for oxygen has been reported to be in
the range of approximately 220-250 μM [29] and refer-
ences therein. This is slightly higher than the maximal
solubility of oxygen in water, which sets a theoretical
upper limit for intracellular oxygen concentrations.
Thus, the biologically relevant range of oxygen-tensions
must be below this value. The KM of FIH for oxygen
has been reported to be lower than the KM of the PHDs
[30], which we take into account. We normalise to the
maximal amount of HIFa, Htot
max =1, which is reached
at steady state in the absence of oxygen-dependent
degradation. Three parameters define HIFa ODD-
hydroxylation, the dissociation constant of the PHD/
HIFa interaction, K D
P  ; the maximal reaction rate,  max
P ;
and the PHD concentration, Ptot.W eu s e dt h er e p o r t e d
value of 1 μM for the PHD/HIFa binding affinity [29], i.
e. K D
P  =1. We then chose  max
P such that a good agree-
ment with measured signal/response curves was
obtained [31]. PHD expression levels relative to HIFa
are not known, and the concentration of PHD was set
to 0.2, an assumption which does not affect any of our
conclusions. In our simulations, the overall rate of FIH
hydroxylation must be higher than the overall rate of
PHD hydroxylation for significant HIFa CAD-hydroxy-
lation to occur. The means by which high FIH activity is
achieved are irrelevant for our conclusions (data not
shown), whether by higher expression levels, higher affi-
nity for HIFa or a faster turnover rate. We thus intro-
duce an arbitrary five-fold excess of FIH over PHD,
which allows us to clearly illustrate the inhibitory effect
of the ARD proteins on FIH activity. The binding affi-
nity of FIH for HIFa and the turnover rate are set to
match the values for PHD. In vivo, FIH activity might
be lower than assumed in the model, however all our
conclusions are qualitative and thus entirely indepen-
dent of these assumptions. Table 2 summarises the
dimensionless parameter values that were used for cal-
culating the graphs shown, unless indicated otherwise in
the figure legends. The model can be found in the Bio-
Models Database, http://www.ebi.ac.uk/biomodels/
accession number MODEL1008170000.
Results
Potential ankyrin-type FIH targets in the human
proteome
To investigate the potential extent of ARD protein inter-
action with FIH, we initially carried out bioinformatic
analyses. Searching the SMART [22], PFAM [23] and
Uniprot [24] databases for human AR-sequences, we
found 1505 annotated ankyrin repeats (ARs) mapping to
252 distinct human ARD proteins. All 1505 ARs were
assembled into a database (Additional File 1) and ana-
lysed for the presence of a potential FIH hydroxylation
site. Diagnostic features were then extracted from
experimentally verified target sequences to aid the pre-
diction of AR-type FIH substrates and give an estimate
of their overall abundance.
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FIH substrate is the presence of a hydroxylatable residue
in the loop region downstream of the second a-helix,
located at position 29 of the prototypical 33 residue
ankyrin repeat consensus sequence (Figure 1A). A total
of 922 human AR (61%) were found to contain one or
more asparagines within the loop region, i.e. between
positions 25 and 33 of the repeat. This subgroup was
termed Asn-repeats, and all are potential FIH targets.
The remaining 584 human AR (39%) lack an asparagine
between consensus positions 25 and 33 (non-Asn-
repeats). Experimental studies have identified a number
of ARs that are hydroxylated by FIH either in vivo or at
least in vitro (Additional File 3, Table S1), or interact
with FIH (Additional File 3, Table S2). Comparison of
the sequences of ARs that are hydroxylated in vivo with
the hydroxylation motif in the C-terminal transactiva-
tion domain of HIFa reveals several conserved features
that might allow prediction of whether or not a given
AR is an FIH target (Figure 1B). All but one FIH target-
repeats verified as such in vivo have a leucine residue at
position -8 relative to the hydroxylated asparagine (L
-8N
group), which is also present in HIFa and in the AR
consensus sequence. Other features found in HIFa that
are also commonly present in verified ankyrin-type in
vivo substrates of FIH are a hydrophobic residue (valine
or isoleucine) at position -1 relative to Asn-29, a polar
residue such as glutamic acid or aspartic acid/asparagine
in position -2, and an alanine or cysteine at position -3
relative to the Asn-29, which may be important in bind-
ing to the active site of FIH [13]. To investigate a possi-
ble correlation between the presence of an L
-8Nm o t i f
and the conservation of the residues at positions -3, -2
and -1 relative to Asn-29, we compared alignments of
L
-8N repeats (Figure 1C) and ARs lacking an L
-8N motif
(Figure 1D). Sequence logos [32] of alignments of all
ARs (Figure 1E) as well as of experimentally verified
hydroxylation targets (Figure 1F) are shown for compar-
ison. We found that the features conserved between
HIFa and verified ankyrin-type hydroxylation targets are
A. The human ankyrin repeat consensus sequence
DGRTPLHLAARNGHLEVVKLLLEHGADVN ARDK
1      2     3     4     5    6     7     8     9    10   11   12    13   14   15  16   17   18   19   20  21   22   23   24   25   26   27   28   29   30    31   32   33 
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B. In vivo FIH substrates
AR Consensus    LLEHGADVNARDK
TNKS2|678-710   LLQHGADVNAQDK
ANFY1|769-801   LLEFGANVNAQDA
ASB4 |207-250   LLDYKAEVNARDD
NFKB1|650-682   LVAAGADVNAQEQ
IKBA |182-214   LVSLGADVNAQEP
TNKS2|711-743   LIKYNACVNATDK
TNKS2|558-590   LVKHGAVVNVADL
ANFY1|288-320   LIKNGAFVNAATL
RN5A |167-200   LDEMGADVNACDN
MYPT1|72-104    LVENGANINQPDN
IKBA |216-248   LLKCGADVNRVTY
ANFY1|457-489   LATNGAHVNHRNK
MYPT1|39-71     LLHRGADINYANV
MYPT1|198-230   LIQAGYDVNIKDY
NOTC1|1928-1960 LLEASADANIQDN
ANFY1|724-756   LIRSGCDVNSPRQ
TNKS2|419-431   VVKHEAKVNALDN
HIF1A|775-807   LTSYDCEVNAPIQ
HIF2A|819-851   LTRYDCEVNVPVL
                        *    
L
L
Figure 1 Bioinformatic analysis of human ankyrin repeats. A. The human ankyrin repeat consensus sequence. Asn-29 in the loop region is
the hydroxylation site. The consensus sequence obtained differs at position 1 (N -> D) and position 31 (K -> R) from a previously reported
consensus obtained by aligning ARs without restriction to a particular species [41]. Secondary structural elements are indicated. B. Experimentally
verified in vivo hydroxylation targets of FIH. Conserved residues are highlighted. The ankyrin consensus as well as the hydroxylation regions of
HIF1/2a are given for comparison. C-F. Sequence alignments. Different subgroups of human ankyrin repeats were aligned and displayed as
sequence logos [32]. The analysis was restricted to repeats with a length of 32-34 residues (~90% of repeats). Note the much higher degree of
conservation in L
-8N repeats (C) when compared to non-L
-8N repeats (D). Alignments of all human ARs (E), and of verified ankyrin-type in vivo
substrates of FIH (F) are given for completion.
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-8N-repeats compared to
ARs without an L
-8N motif (compare Figures 1C and
1D). Thus, the presence of an L
-8N motif seems to cor-
relate with the presence of several additional features
that are also present in HIFa, and thus appears to
d e f i n eas u b g r o u po fh u m a nA R s ,w h i c hl i k e l yc o n t a i n s
most FIH target repeats. It is tempting to speculate that
the higher degree of conservation found in positions -1,
-2 and -3 relative to Asn-29 has been maintained in the
L
-8N group because these residues are important for
FIH-dependent hydroxylation. However, other explana-
tions such as structural requirements are also possible.
Overall, we analysed and classified 1505 individual
human ankyrin repeats (Table 3). We find that 472
human ankyrin repeats (31%) in 182 distinct ARD pro-
teins contain an L
-8N motif. Applying more stringent
criteria, the most likely ankyrin-type hydroxylation tar-
gets of FIH have the consensus sequence 21-L(X)4(AC)
(DEN)(ILV)N-29, which is found in 166 ARs mapping to
105 ARD proteins. Thus, 166 likely is a lower limit for
the number of ankyrin-type FIH asparaginyl-hydroxyla-
tion targets. The large number of AR-type FIH targets
supports the idea that FIH-hydroxylatable ARD proteins
can compete with HIFa for FIH binding. How this
would contribute to the suggested “fine-tuning” of HIF-
regulation is however not obvious, because a strong,
constitutive sequestration of FIH by ARD proteins
would merely attenuate FIH activity towards HIFa at all
oxygen concentrations. Also, the affinity of FIH for
ARDs can be higher than its affinity for HIFa [33,34],
and it is difficult to envisage how HIFa CAD-hydroxyla-
t i o nc a no c c u ra ta l li nt h ep r e s e n c eo fs u c hal a r g e
pool of efficient competitors. However, hydroxylation of
ARs has been shown to significantly decrease their affi-
nity for FIH [13], suggesting that FIH, by hydroxylating
ARs in an oxygen dependent manner, is able to trigger
its own release from ARD protein sequestration
[12,14,21]. To test this proposal and to investigate its
implications for the hypoxic response, we devised and
analysed a rate equation model describing these
processes.
Kinetic modelling
We set out to model the scenario that, under normoxic
conditions, when the catalytic activity of FIH is high,
more ARs will be hydroxylated and thus less able to
bind and sequester FIH, a larger proportion of which
will be free to target HIFa. When oxygen becomes lim-
iting under hypoxic conditions, FIH catalytic activity will
decrease, the fraction of unhydroxylated ARs will rise,
and FIH will be sequestered from HIFa more efficiently.
In a modular approach, we first analysed two skeleton
models, each aimed at capturing the essence of a dis-
tinct aspect of the system (Figure 2). Skeleton Model 1
(SKM1) describes the reactions affecting HIFa (basal
HIFa turnover, ODD-hydroxylation-induced degradation
of HIFa,H I F a CAD-hydroxylation), but ignores the
presence of ARD proteins. Skeleton Model 2 (SKM2)
describes the reactions affecting ARD proteins (basal
ARD protein turnover, FIH binding to ARD proteins,
their hydroxylation, and hydroxylation-dependent FIH-
release). Because of their parsimony, the skeleton mod-
els provide significant insight into the logic of these pro-
cesses. Both skeleton models were then fused into a Full
Model, which we used to study if and how oxygen-regu-
lated competitive inhibition by ARD proteins can shape
the hypoxic response. The XPP-AUT modelling file is
provided as Additional File 4.
Skeleton Model 1 - HIFa CAD-hydroxylation in the
absence of the FIH/AR-interaction
By targeting HIFa for degradation in an oxygen-depen-
dent manner, PHD activity restricts the amount of HIFa
that is available for FIH-dependent HIFa CAD-hydroxy-
lation (Figure 3A, bold black curve). Oxygen-dependent
FIH activity then determines the fraction of total HIFa
that is CAD-hydroxylated. Increasing FIH activity shifts
the curve of non-CAD-hydroxylated HIFa to the left
towards lower oxygen-tensions (Figure 3A). Thus, the
higher FIH activity, the more severe the hypoxia that is
required to induce transcription of CAD-dependent tar-
get genes. The model predicts two regions of distinct
gene expression, which are defined by the oxygen-ten-
sion (Figure 3B). A decrease in oxygen-levels first leads
into a regime where hypoxia response elements (HRE)
start to become occupied by accumulating HIF, however
a lot of the occupying HIF contains CAD-hydroxylated
HIFa. In this region, NAD-dependent genes are
expressed (Figure 3B, grey shading), but CAD-depen-
dent genes remain repressed. The model predicts that a
further decrease in oxygen-levels will cause non-CAD-
hydroxylated HIFa to increase sufficiently to allow
expression of CAD-dependent genes. In this regime,
both NAD- and CAD-dependent genes are expressed
(Figure 3B, green shading). The prediction that more
Table 3 Classification of ankyrin-repeats according to
sequence motifs
Group Total % of all
AR
Asn-hydroxylation
targets?
all L
-8N, 472 31% Likely
of which L(X)4(AC)(DEN)
(ILV)N
166 11%
Asn-repeats, non L
-8N 449 30% Unlikely
Non-Asn-repeats 584 39% No
Total 1505 100%
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Page 7 of 17Figure 2 Schematic of the reaction network. Model reactions are indicated by bold arrows, the corresponding rate constants (k)o rr a t e
functions (ν) are indicated. Note that here complex formation between FIH and ARD proteins is shown explicitly for clarity, however in the
model this reaction is assumed at steady state and implicit in the AR-hydroxylation rate function, νFA. Also, binding of FIH to hydroxylated ARs is
accounted for in the Full Model, but not shown in this schematic. Skeleton Models 1 (SKM1, red shading) and 2 (SKM2, green shading) describe
subsystems of the full system. ARD, ankyrin-repeat domain proteins. ks
A , ks
H , synthesis rates of ARDs and HIFa, respectively. kd
A , kd
H , basal
degradation rates of ARDs and HIFa, respectively. νP, νFH and νFA, rate functions for HIFa ODD-, HIFa CAD-and ARD protein-hydroxylation,
respectively.
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(a = 1) represents the case where all kinetic parameters for FIH and PHD are identical. B. Activation status of hypoxia-response elements (HREs).
Probabilities for an HRE to be bound by either HIFa that is not CAD-hydroxylated (green solid curve), by CAD-hydroxylated HIFa (red dotted
curve) or either form of HIFa (bold black curve) under the assumption that all forms of HIF bind with identical affinity to the HRE
( K D
HRE  = 03 . ). We propose the existence of a novel set of HIF target genes, which are transcriptionally activated by CAD-hydroxylated HIFa
(CADOH-dependent genes). The regimes of differential gene expression are indicated by shading (an arbitrary gene activation threshold was
introduced at 20% HRE occupancy). Parameters used were as in A, with a = 0.33[30].
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Page 8 of 17severe hypoxia is required to activate CAD-dependent
genes than to activate NAD-dependent genes is consis-
tent with previous experimental results [7].
Experimentally, CAD-dependent genes, but not NAD-
dependent genes, are induced by FIH knockdown and
repressed by FIH overexpression [7]. Interestingly, a
third group of HIF target genes have been described,
which show the opposite behaviour to CAD-dependent
genes. This group, one member of which is BNIP3
(BCL2/adenovirus E1B 19 kD interacting protein 3), is
repressed by FIH knockdown and de-repressed by FIH
overexpression [7,35]. To explain this unexpected beha-
viour, a CAD-dependently expressed repressor was pos-
tulated, which would be present only at very low oxygen
concentrations [7]. Our model suggests a more parsimo-
nious explanation, which can explain the unusual beha-
viour of some HIF target genes. We propose that BNIP3
belongs to a third, novel class of target genes, which are
specifically activated by the CAD-hydroxylated HIFa
(CADOH-dependent, Figure 3B, red shading), and thus
expressed in a p300/CBP-independent manner. This
proposal assigns a potential direct function to CAD-
hydroxylated HIFa, and we studied the behaviour of this
species in more detail. Because FIH activity is a monoto-
nically increasing function of oxygen, the naive expecta-
tion is that the amount of CAD-hydroxylated HIFa
should also increase monotonically (at least until a
saturation point) with increasing oxygen-levels. The
model predicts however that this is not the case and
that the level of CAD-hydroxylated HIFa will peak at
intermediate oxygen tensions. The location and magni-
tude of the peak of CAD-hydroxylated HIFa are para-
meter dependent, but its existence is a generic system
property. The postulated group of CADOH-dependent
genes is thus predicted to be expressed at intermediate
hypoxia only (Figure 3B), and to show the bell-shaped
signal/response curve observed experimentally [7].
Skeleton Model 2 - FIH sequestration by ARD proteins
and oxygen-dependent FIH-release
By ignoring the presence of HIFa,S K M 2r e d u c e st h e
system to the sequestration of FIH by ARD proteins,
their hydroxylation, and the subsequent oxygen-depen-
dent FIH-release and allows us to define the require-
ments for an “efficient”, FIH-release, which we define as
a clear differential between the levels of free FIH at
high and low oxygen concentrations. Two non-dimen-
sional parameters determine the system behaviour (Fig-
ure 4): The sequestration capacity of the ARD protein
pool (), which depends on the total concentration of
ARs and their affinity for FIH; and the hydroxylation
efficiency (b), which is the νmax of the hydroxylation
rate of ARD proteins relative to their degradation rate,
and thus relates the rate of AR-hydroxylation to the
rate of ARD protein turnover. The signal/response
curves (Figures 4A, B) indicate that an efficient FIH-
release requires both the sequestration capacity  and
the hydroxylation efficiency b to be large. At low oxy-
gen-tensions, the steady state is largely determined by
, and the larger , the lower the level of free FIH (Fig-
ure 4A). At high oxygen-tensions, the steady state is
determined chiefly by b.Al a r g eb value causes a large
fraction of ARs to be in the hydroxylated state and thus
incapable of retaining FIH, particularly at high oxygen-
levels (Figure 4B). The conditions that allow an efficient
and sharp oxygen-dependent release of FIH from ARD
protein-dependent sequestration are identical to those
that favour near-complete hydroxylation of FIH-target
repeats. Thus, SKM2 predicts that near-complete hydro-
xylation of the FIH-accessible fraction of hydroxylatable
target repeats is required for efficient, oxygen-dependent
FIH-release.
In addition to this steady state analysis, we also simu-
lated the temporal response of the system to step
changes in oxygen concentrations, i.e. to sudden hypoxia
and to sudden reoxygenation after a hypoxic episode.
SKM2 predicts that the time-resolved response to
hypoxia is rather insensitive to variations of  and b,
with the family of curves showing a hyperbolic decrease
in free FIH with time, either reaching distinct steady
state values at low oxygen when  is varied (Additional
File 3, Figure S1A), or starting out from distinct steady
state values at high oxygen if b is varied (Additional File
3, Figure S1B). More interestingly however, the temporal
response to an increase of oxygen after hypoxia (reoxy-
genation) is affected significantly by both,  and b.
Although variations in  affect half-response times for
FIH-release only moderately (Figure 4C), varying  does
significantly mould the shape of the time-response
curves, which change from a gradual FIH-release if  is
small, to a delayed, switch-like FIH-release if  is large
(Figure 4C). In contrast to varying , varying b substan-
tially affects half response times - the larger b, the faster
the FIH release in response tor e o x y g e n a t i o n( F i g u r e
4D). Thus, SKM2 predicts that oxygen-dependent FIH-
release from ARD proteins upon sudden reoxygenation
of hypoxic cells can occur in a switch-like manner, with
at i m ed e l a yr e l a t i v et ot h er e o x y g e n a t i o ne v e n t .T h e
reason for this time delay is that, shortly after reoxy-
genation, the concentrationo fu n h y d r o x y l a t e d ,F I H -
accessible ARs is still high enough to allow rebinding of
any released FIH. SKM2 thus predicts that a permanent
release of FIH is only achieved once the FIH-accessible
ARs are hydroxylated to a significant extent, and the
concentration of unhydroxylated ARs starts to become
limiting for FIH sequestration, which, due to the excess
Schmierer et al. BMC Systems Biology 2010, 4:139
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Page 9 of 17of ARs over FIH, can only happen if hydroxylation of
FIH-accessible ARs approaches completion. The time
required for FIH to hydroxylate ARs to a sufficient
degree to overcome sequestration explains the time
delay between reoxygenation and FIH-release. This
behaviour also allows modulation of the timing of FIH-
release as a function of the strength and duration of the
preceding hypoxic episode, a feature we explore using
the Full Model at the end of the following section.
The Full Model - the effects of the FIH/ARD protein
interaction on HIFa CAD-hydroxylation
Having simulated the interdependency of HIFa CAD-
hydroxylation and oxygen-dependent degradation of
HIFa (SKM1), as well as the requirements for efficient,
oxygen-dependent release of FIH from ARD proteins
(SKM2), we next fused the skeleton models into a Full
Model, which we use to investigate the effects of ARD
protein hydroxylation on the steady state levels and the
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Page 10 of 17temporal response of HIFa CAD-hydroxylation. If the
conditions for efficient FIH-release as previously defined
by analysis of SKM2 are met, the Full Model predicts a
similar sharp and efficient FIH-release above an oxygen
threshold, and additionally suggests that this feature is
robustly retained over a wide range of ARD protein con-
centrations. The position of the oxygen threshold for
FIH-release is predicted to be determined by the total
number of ARs that are FIH targets (Figure 5A, left
hand panel). Importantly, the oxygen-threshold for FIH-
release translates into an oxygen-threshold for HIFa
CAD-hydroxylation (Figure 5A, right hand panel). Below
the threshold, non-CAD-hydroxylated HIFa is kept at
high levels. The drop at the oxygen threshold is much
sharper than in the absence of an FIH/AR-interaction
(green solid curves, compare Atot =0w i t he . g .Atot =
1 0 0 ,s e ea l s oF i g u r eS 2 ) .I n c r e a s i n gt h en u m b e ro fF I H -
accessible ARs shifts the oxygen threshold and the
decreasing peak values of CAD-hydroxylated HIFa
towards higher oxygen-tensions and narrows the oxygen
range in which CAD-hydroxylated HIFa can accumulate
(Figure 5A, right hand panel). Overall, the Full Model
predicts that competition by ARD proteins for FIH
introduces an ultrasensitive dependence of HIFa CAD-
hydroxylation on oxygen levels. The position of the oxy-
gen threshold above which HIFa CAD-hydroxylation
occurs is determined by the concentration of AR-type
hydroxylation targets, as is the range of oxygen tensions
into which HIFa CAD-hydroxylation is focused. We
conclude that the FIH/AR-interaction can cause HIFa
CAD-hydroxylation to respond ultrasensitively to chan-
ging oxygen levels, and that it can contribute to deter-
mining the oxygen-range or the degree of hypoxia at
which CAD-hydroxylated HIFa will accumulate.
Up to now we have assumed that FIH does not bind
a ta l lt oh y d r o x y l a t e dA R s .T om a k et h eF u l lM o d e l
more realistic, we now allow such product binding to
happen and introduce a parameter 0 <g <1 ,w h i c hi s
the binding affinity of FIH for hydroxylated ARs relative
to its affinity for unhydroxylated ARs. It becomes clear
that even weak binding of FIH to hydroxylated ARs (g <
1) can strongly attenuate the levels of free FIH at high
oxygen tensions (Figure 5B, left hand panel). The peak
values of CAD-hydroxylated HIFa (Figure 5B, right
hand panel) are also decreased. Importantly however,
while binding of FIH to hydroxylated ARs attenuates the
steepness of the response curve, the existence of an oxy-
gen threshold is entirely independent of such binding.
Experiments suggest that there is indeed a substantial
differential between the FIH binding affinity for non-
CAD-hydroxylated versus CAD-hydroxylated ARs [13],
and we predict that this difference is essential for
achieving significant HIFa CAD-hydroxylation and the
sharpest possible response curves.
FIH-dependent Asn-hydroxylation is, to the best of
our knowledge, irreversible and can only be reversed
indirectly by degradation of the Asn-hydroxylated pro-
teins and de novo synthesis of unhydroxylated proteins.
Thus, the mean life times of the competing substrates,
ARD-proteins and HIFa, are expected to be important
parameters. To test this, we varied the parameter ε,
which is the ratio of the mean life time of ARD-proteins
relative to the mean life time of HIFa under basal turn-
over conditions, i.e. in the absence of oxygen. The Full
Model predicts that long-lived ARD proteins (large ε )
decrease the oxygen-tension at which FIH-release occurs
(Figure 5C, left hand panel). Consequently, if ε is large,
FIH is already released at oxygen-tensions at which
PHD-activity is still only moderate, and a substantial
amount of HIFa is available for CAD-hydroxylation,
leading to increased peak values of CAD-hydroxylated
HIFa and a sharper response (Figure 5C, right hand
panel). The exact value of ε then determines both the
degree of hypoxia at which HIFa CAD-hydroxylation
can occur, and the extent to which CAD-hydroxylated
HIFa can accumulate.
In addition to these steady state calculations, we also
used the Full Model to simulate the effect of the FIH/
AR-interaction on the temporal behaviour of the sys-
tem in response to both hypoxia and to reoxygenation
after hypoxia. We compared the hypothetical case of
constitutive FIH activity (no FIH/AR-interaction) with
the situation where FIH activity is regulated by ARs
through sequestration and oxygen-dependent release.
The simulations were performed for two different
degrees of hypoxia, severe and moderate. In the case
of constitutively active FIH, reoxygenation from severe
hypoxia is predicted to cause a strong and transient
burst in HIFa CAD-hydroxylation at early time points
after reoxygenation (Figure 6A, red curve), which is
attenuated if the preceding hypoxia was moderate (Fig-
ure 6B, red curve). Irrespective of the strength of the
preceding hypoxic episode, in the absence of an FIH/
AR-interaction nearly all HIFa is predicted to become
CAD-hydroxylated prior to its oxygen-dependent
degradation (Figures 6A, B). In the presence of an
FIH/AR-interaction by contrast, the Full Model pre-
dicts the existence of a temporal threshold for FIH-
release, which now occurs with a time delay in a
switch-like fashion (Figures 6C and 6D, blue curves).
These results are consistent with the predictions by
SKM2 (Figure 4E, F). As a consequence of the delayed
FIH-release, and in stark contrast to the case of consti-
tutive FIH activity, the Full Model predicts that nearly
all HIFa is degraded before its CAD can be hydroxy-
l a t e d( F i g u r e6 Ca n d6 D ) ,w h i c hp r e c l u d e st h eb u r s to f
HIFa CAD-hydroxylation upon reoxygenation seen in
the case of constitutively active FIH (compare Figures
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Figure 5 Full Model, signal/response curves for varying parameter values. Steady state concentrations of free FIH (blue), and of
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higher the oxygen-tension at which FIH is released (left hand panel). Competing ARs also create an oxygen-threshold for CAD-hydroxylation,
above which non-CAD-hydroxylated HIFa drops much more sharply with increasing oxygen levels than in the case where there is no
competition (right hand panel, green solid curves). In addition, the FIH/AR-interaction restricts the presence of CAD-hydroxylated HIFa to
moderate hypoxia and decreases its peak values (right hand panel, red dotted curves). In contrast to B and C, here FIH is assumed to not bind
to hydroxylated ARs at all. B. Binding of FIH to hydroxylated ARD proteins has to be weak for efficient FIH-release. g, the FIH affinity for
hydroxylated relative to unhydroxylated ARs, must be small for both efficient FIH-release (left hand panel) and efficient HIFa CAD-hydroxylation
(right hand panel). C. ARD proteins must be stable compared to the basal stability of HIFa for efficient HIFa CAD-hydroxylation to occur. Large ε
indicates stable ARD proteins, which allows FIH-release to occur at lower oxygen levels (left hand panel). Large ε increases extent and sharpness
of HIFa CAD-hydroxylation and shifts the peak value to more severe hypoxia (right hand panel).
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Figure 6 Time course simulations in the Full Model. A-D. Response to reoxygenation. Reoxygenation in the hypothetical case of
constitutively active FIH that is not affected by competing ARs (A and B) or in the case of an FIH/AR-interaction (C and D), from either severe
hypoxia (  O2 = 0.001, A and C, dark grey area) or moderate hypoxia (  O2 = 0.01, B and D, light grey area) to normoxic conditions (  O2 = 0.5)
at t = 0. E, F. Response to hypoxia in the case of an FIH/AR-interaction. At t = 0, oxygen levels were changed from normoxic (  O2 = 0.5) to
either severely hypoxic (  O2 = 0.001, E, dark grey area) or moderately hypoxic (  O2 = 0.01, F, light grey area). For completion, the behaviour in
response to the same changes in oxygen levels but in the hypothetical absence of an FIH/AR-interaction is shown in Additional File 3, Figure S3.
Parameters were Atot = 100, g = 0.02 and ε = 5 for all of Figures 6 and S3. Time is given in units of the mean life time of HIFa in the absence of
oxygen (τH).
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Page 13 of 176A and 6C, red curves). The length of the delay in
FIH-release depends on the hydroxylation status of the
ARD protein pool. Because more severe, or longer,
hypoxia leads to a higher fraction of FIH-binding ARs
to be unhydroxylated, more time is required for FIH to
hydroxylate these substrates and to trigger its own
release (compare Figures 6C and 6D, blue curves and
black dotted curves). The delay in FIH-release thus is a
direct readout of the hydroxylation status of the ARD
protein pool, which in turn reflects both the strength
and the duration of the preceding hypoxic episode.
This idea relies on the following model predictions:
Firstly, the rate of accumulation of unhydroxylated
ARs during hypoxia is counteracted by residual FIH
activity and is thus dependent on the hypoxic oxygen
tension (compare Figures 6E and 6F, slope of the
dotted curves). Secondly, because Asn-hydroxylation is
irreversible, the replacement of hydroxylated ARD pro-
teins with their unhydroxylated counterparts during
hypoxia is a slow process limited by de novo protein
synthesis (compare the reoxygenation time scale in
Figures 6A-D with the hypoxia timescale in Figures 6E,
F). Due to the slow accumulation of unhydroxylated
ARD proteins in hypoxia, which additionally depends
on the residual FIH-hydroxylation activity and thus the
degree of hypoxia, the hydroxylation status of the ARD
p r o t e i np o o lc a nm e a s u r ea n di n t e g r a t eaw i d er a n g e
of hypoxic strengths and durations. At the time of
reoxygenation, the hydroxylation status of the ARD
protein pool will reflect these characteristics of the
hypoxic episode, which then translate into a delay for
FIH-release. For completion, the temporal behaviour in
response to hypoxia in the absence of an FIH/AR-
repeat interaction is shown in the Additional File 3,
Figure S3.
In summary, steady-state simulations with the Full
Model suggest that, in the absence of other variables, a
low binding affinity of FIH for already hydroxylated
ARs, as well as a fast basal turnover of HIFa compared
to the average turnover of ARD proteins are essential
requirements for efficient HIFa CAD-hydroxylation.
The model predicts two functionally significant effects
of oxygen-dependent FIH-release from ARD proteins,
which are emergent system properties that shape the
hypoxic response: The process of HIFa CAD-hydroxyla-
tion is focused into a defined range of oxygen-tensions
(range-finding mechanism), and the signal/response
curves are significantly sharpened (ultrasensitivity). Time
course simulations further suggest that a delay in FIH-
release in response to reoxygenation provides a readout
of the hydroxylation status of the ankyrin-pool, which in
turn encodes or “memorises” duration and strength of
the preceding hypoxic episode.
Discussion
Several kinetic models of the HIF-pathway have been
reported, each focusing on different aspects of this sig-
nalling system [35-38]. Only one of these models con-
siders FIH and HIFa CAD-hydroxylation, but this does
not include ARD proteins as competing FIH substrates
[35]. Predictions derived from SKM1, which ignores the
FIH/AR-interaction, support previous experimental [7]
and theoretical work [35]. Despite its simplicity, SKM1
successfully reproduces the findings that, first, expres-
sion of CAD-dependent genes requires more severe
hypoxia when compared to NAD-dependent genes, and
second, that higher FIH activity increases the magnitude
of this shift towards severe hypoxia (Figure 3). These
features are generic properties that are valid whether or
not the FIH/AR interaction is taken into account. Our
proposal that there is an additional group of target
genes that relies on the hydroxylated CAD for transcrip-
tional activation in a CBP/P300-independent manner
provides a possible explanation for the unusual activa-
tion profile of HIF target genes such as BNIP3 [7]. The
existence of such a target gene group however requires
experimental verification. Because FIH needs to compete
with PHD-induced degradation of HIFa, SKM1 predicts
that HIFa CAD-hydroxylation can only occur to a sig-
nificant extent if FIH-dependent hydroxylation is at
least as effective as PHD-dependent hydroxylation (see
a = 1 in Figure 3A for identical activities of FIH and
PHDs). This is true even in the hypothetical absence of
an inhibitory FIH/AR-interact i o n ,i . e .i fF I H - a c t i v i t y
towards HIFa is constitutive and maximal. Indeed, FIH
has been suggested to be a more efficient enzyme than
the PHDs because of its lower KM for oxygen, for which
there is in vitro evidence [30]. Our SKM1 predictions
modify this notion, indicating that efficient HIFa CAD-
hydroxylation does not specifically depend on the KM of
FIH for oxygen, but more generally on intracellular FIH
activity. Expression levels of FIH relative to PHDs thus
are predicted to play a major role in vivo in determining
the extent of HIFa CAD-hydroxylation at a given oxy-
gen tension, and accurate measurements of relative
expression levels of FIH and PHDs are desirable.
The focus of our work was on the regulation of FIH
activity towards HIFa through competitive inhibition by
ARD proteins. The large number of ARD proteins, a
substantial fraction of which we predict to be FIH tar-
gets, and the fact that at least some isolated ankyrin-
domains bind more tightly to FIH than to HIFa [13,39]
make it seem possible that ARs will out-compete HIFa
and prevent significant HIFa CAD-hydroxylation irre-
spective of the oxygen concentration. However, HIFa
clearly is CAD-hydroxylated by FIH in vivo,a n dac o n -
clusive theory needs to consolidate this fact with the
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Several factors can potentially contribute to weakening
the competition by ARD proteins for FIH. First, not all
ARD proteins are expected to be expressed in a particu-
lar cell type. Second, the ARD is a protein-protein inter-
action motif, and only a fraction of a given ARD protein
is expected to be accessible to FIH in vivo. Third, affi-
nity constants measured in vitro with isolated protein
domains might be misleading. These considerations
make it difficult to give an estimate of a realistic con-
centration of FIH binding target repeats, and FIH
sequestration could be much less pronounced than
expected from idealised theoretical considerations. Irre-
spective of its actual extent however, FIH sequestration
by ARD proteins must be oxygen-regulated in order to
tune HIFa CAD-hydroxylation, other than just repres-
sing it at all oxygen tensions, and experimental evidence
points to hydroxylation-dependent release of FIH from
ARD-proteins as the responsible mechanism. SKM2 pre-
dicts that such FIH-release only occurs if hydroxylation
of FIH-accessible ARs approaches completion. Impor-
tantly, this prediction is not in contrast with experimen-
tal findings indicating that the hydroxylation of an
individual AR is often far from complete, even under
conditions of high oxygen [11,13,15]. Because the ARD
is a protein-protein interaction domain, the access of
FIH to the ARDs will be restricted by the presence of
ARD-interactors other than FIH, which will partly pro-
tect ankyrin repeats from FIH-dependent hydroxylation.
Thus, it is possible that near-complete hydroxylation of
a specific AR may not be observed experimentally, but
the hydroxylation of its FIH-accessible fraction might
still approach completion.
We identify several potential functional effects of the
FIH/AR-interaction on HIFa CAD-hydroxylation. The
Full Model predicts that the FIH/AR-interaction intro-
duces an oxygen-threshold, below which HIFa CAD-
hydroxylation is marginal and CAD-dependent genes
are fully active. The exact threshold concentration of
oxygen, above which HIFa CAD-hydroxylation can
occur and CAD-dependent genes are turned off, is pre-
dicted to be determined by the total amount of FIH-
accessible, hydroxylatable ARs, their binding affinity for
FIH, as well as by the relative turnover rates of HIFa
and ARD proteins and should thus be tunable by modu-
lating these system features. A range finding property is
essential for the HIF hydroxylases to act as oxygen sen-
sors in environments with different physiologically rele-
vant ranges of oxygen concentrations [1]. Although it is
unlikely that the FIH/AR-interaction is the only range-
finding mechanism in the HIF system, our results
demonstrate that it is one possible such mechanism.
T h ec h a n g ei nC A D - h y d r o x y l a t i o na tt h eo x y g e n
threshold is significantly sharpened compared to the
absence of an FIH/AR-interaction. Such ultrasensitivity,
as characterised by a sigmoid signal/response curve, is
an important feature of many signalling pathways and
cellular decision making processes. Mechanisms giving
rise to ultrasensitive behaviour include cooperativity,
multi-site modification, zero-order ultrasensitivity, and
positive feedback. In our case, the mechanism causing
ultrasensitivity is similar to a proposed “ultrasensitivity
by substrate competition”, where stoichiometric inhibi-
tion of an enzyme by a competing substrate can make
enzyme activity for other substrates nonlinearly depen-
dent on the enzyme level [40]. Finally, time course
simulations using SKM2 (Figure 4) and the Full Model
(Figure 6) predict that FIH-release can occur in a
switch-like fashion with a time delay after reoxygenation
of hypoxic cells. The length of this delay depends on the
intensity and the duration of the preceding hypoxic per-
iod. Functionally, this time delay in FIH-release can pre-
vent a premature FIH-release during a brief and perhaps
only transient reoxygenation event, and only sustained
reoxygenation will trigger bulk FIH-release.
Conclusions
Overall, the combined modelling results reveal that the
interaction of multiple ARD proteins with FIH has the
potential to significantly input on the dynamics of the
hypoxic response in human cells. The FIH/AR-interac-
tion can provide a mechanism by which the oxygen-
threshold for the hypoxic response can be varied (range
finding mechanism), it can confer substantial sharpening
of the signal/response curves (ultrasensitivity), and it
can create a time-delay for CAD-hydroxylation after
reoxygenation, the length of which can encode the
strength and duration of the preceding hypoxic episode
(a memory effect). The modulation of HIF hydroxylase
activity is of considerable interest with respect to thera-
peutic intervention. Inhibition of the HIF hydroxylases
may be useful for treatment of anaemia and ischemic
disease, via the upregulation of erythropoiesis and angio-
genesis, respectively. Presently, it is unclear whether HIF
hydroxylase inhibitors should target individual HIF
hydroxylases or combinations of enzymes. Our results
reveal that the FIH/AR-interactions should be taken
into account in analyses of the cellular and physiological
effects of HIF hydroxylase inhibitors, whether or not
these inhibitors are selective for PHDs and/or FIH.
Interfering with the binding of FIH to ARD-proteins is
predicted to increase HIFa CAD-hydroxylation, whereas
interfering with AR-hydroxylation by FIH is predicted to
decrease HIFa CAD-hydroxylation. Thus, the FIH/AR-
interaction itself is a promising potential target for phar-
macological modulation of the HIF pathway. Finally, we
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Page 15 of 17note that if the concept of multiple proteins regulating a
signalling sensor occurs in the oxygen sensing HIF-sys-
tem, it is likely to occur in other signalling pathways.
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